source
- FDA warns Evolus over misleading Instagram claims about JeuveauThe FDA's Office of Prescription Drug Promotion sent an untitled warning letter to Evolus, the maker of the injectable cosmetic product Jeuveau. The letter says the company exaggerated the drug’s…
- Bayer to invest $2.2B in new Ohio manufacturing complex as FDA CDER opens clinical trial modernization officeBayer announced plans to spend roughly $2.2 billion on a new manufacturing site in Ohio, aiming to broaden its production capabilities. The investment is projected to increase capacity and generat…